Summary
CryoLife, Inc. (CryoLife) is a biological medical device company. The company develops and commercializes biomaterials, implantable medical devices and surgical adhesives, and also preserves and distributes human tissues for cardiovascular and vascular transplant applications. The company’s product portfolio includes CryoValve SG pulmonary heart valve, CryoPatch SG pulmonary cardiac patch tissue and surgical sealants and hemostats including BioGlue surgical adhesive, BioFoam surgical Matrix, and PerClot absorbable powdered hemostat. The company through its subsidiary Cardiogenesis Corporation specializes in the treatment of coronary artery disease using a laser console system and single use, fiber-optic handpieces to treat patients with severe angina. Additionally, CryoLife and its subsidiary, Hemosphere, Inc. markets the Hemodialysis Reliable Outflow Graft (HeRO Graft). The company distributes its preserved human cardiac and vascular tissues to implanting institutions across the US, Canada, and Europe. CryoLife is headquartered in Georgia, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company CryoLife, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
CryoLife, Inc. Company Snapshot 5
CryoLife, Inc. Company Overview 5
Key Information 5
CryoLife, Inc. Pipeline Products and Clinical Trials Overview 6
CryoLife, Inc. – Pipeline Analysis Overview 8
Business Description 8
Key Facts 8
CryoLife, Inc. - Major Products and Services 9
CryoLife, Inc. Pipeline Products by Development Stage 10
CryoLife, Inc. Clinical Trials by Trial Status 12
CryoLife, Inc. Pipeline Products Overview 13
Biodisc Nucleus Pulposus Replacement 13
Biodisc Nucleus Pulposus Replacement Product Overview 13
CryoValve SGAV 14
CryoValve SGAV Product Overview 14
CryoValve SGAV Clinical Trial 15
EndoClot Absorbable Polysaccharide Hemostat 16
EndoClot Absorbable Polysaccharide Hemostat Product Overview 16
PerClot Express 17
PerClot Express Product Overview 17
PerClot Laparoscopic 18
PerClot Laparoscopic Product Overview 18
PerClot PHS 19
PerClot PHS Product Overview 19
PerClot Topical 20
PerClot Topical Product Overview 20
PHOENIX Combination Delivery System 21
PHOENIX Combination Delivery System Product Overview 21
CryoLife, Inc. - Key Competitors 22
CryoLife, Inc. - Key Employees 23
CryoLife, Inc. - Key Employee Biographies 24
CryoLife, Inc. - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
CryoLife, Inc., Recent Developments 26
May 22, 2014: CryoLife Increases Quarterly Cash Dividend Nine Percent for the Second Quarter 2014 26
Apr 02, 2014: CryoLife Receives FDA Approval to Begin Clinical Trials for PerClot in the U.S. 26
Feb 20, 2014: CryoLife Fourth Quarter 2013 Revenues Increased 8 Percent to a Record $35.5 Million 26
Feb 19, 2014: CryoLife Announces Quarterly Cash Dividend for the First Quarter 2014 28
Feb 18, 2014: CryoLife Announces Expansion in Asia Pacific Markets 28
Nov 25, 2013: CryoLife to Present at 25th Annual Piper Jaffray Healthcare Conference 29
Nov 21, 2013: CryoLife Announces Quarterly Cash Dividend for the Fourth Quarter 2013 29
Nov 05, 2013: CryoLife To Host Second Central Venous Pathology Summit in 2013 29
Oct 29, 2013: CryoLife Third Quarter 2013 Revenues Increase 8 Percent to a Record $36.3 Million 30
Oct 14, 2013: CryoLife Announces Release Date and Teleconference Call Details for 2013 Third Quarter Financial Results 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List Of Tables
List of Tables
CryoLife, Inc., Key Facts 5
CryoLife, Inc. Pipeline Products and Clinical Trials Overview 6
CryoLife, Inc. Pipeline Products by Equipment Type 6
CryoLife, Inc. Pipeline Products by Indication 7
CryoLife, Inc. Clinical Trials by Trial Status 7
CryoLife, Inc., Key Facts 8
CryoLife, Inc., Major Products and Services 9
CryoLife, Inc. Number of Pipeline Products by Development Stage 10
CryoLife, Inc. Pipeline Products Summary by Development Stage 11
CryoLife, Inc. Clinical Trials by Trial Status 12
CryoLife, Inc. Clinical Trials Summary 12
Biodisc Nucleus Pulposus Replacement - Product Status 13
Biodisc Nucleus Pulposus Replacement - Product Description 13
CryoValve SGAV - Product Status 14
CryoValve SGAV - Product Description 14
CryoValve SGAV - CryoValve SG Pulmonary Human Heart Valve Post Clearance Study 15
EndoClot Absorbable Polysaccharide Hemostat - Product Status 16
EndoClot Absorbable Polysaccharide Hemostat - Product Description 16
PerClot Express - Product Status 17
PerClot Express - Product Description 17
PerClot Laparoscopic - Product Status 18
PerClot Laparoscopic - Product Description 18
PerClot PHS - Product Status 19
PerClot PHS - Product Description 19
PerClot Topical - Product Status 20
PerClot Topical - Product Description 20
PHOENIX Combination Delivery System - Product Status 21
PHOENIX Combination Delivery System - Product Description 21
CryoLife, Inc., Key Employees 23
CryoLife, Inc., Key Employee Biographies 24
CryoLife, Inc., Subsidiaries 25
List Of Figures
List of Figures
CryoLife, Inc. Pipeline Products by Equipment Type 6
CryoLife, Inc. Pipeline Products by Development Stage 10
CryoLife, Inc. Clinical Trials by Trial Status 12
